A randomized, multicentre trial evaluating the efficacy and safety of fast‐acting insulin aspart in continuous subcutaneous insulin infusion in adults with type 1 diabetes (onset 5)

AIM: To evaluate the efficacy and safety of fast‐acting insulin aspart (faster aspart) vs insulin aspart (IAsp) used in continuous subcutaneous insulin infusion (CSII) in participants with type 1 diabetes (T1D). MATERIALS AND METHODS: This was a double‐blind, treat‐to‐target, randomized, 16‐week tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Klonoff, David C., Evans, Mark L., Lane, Wendy, Kempe, Hans‐Peter, Renard, Eric, DeVries, J. Hans, Graungaard, Tina, Hyseni, Agon, Gondolf, Theis, Battelino, Tadej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590130/
https://www.ncbi.nlm.nih.gov/pubmed/30537180
http://dx.doi.org/10.1111/dom.13610

Ejemplares similares

Ejemplares similares